DNDN is rallying big (up about 20% at one point) following a favorable CNBC report featuring urologists who say their patients are practically begging them for the company's Provenge prostate cancer treatment and even personally appealing to the FDA. I distracted when they mentioned a web site appealing to the FDA to approve the drug. Will get a link when I can find one, or maybe someone can provide the link in the comments section.
Not mentioned on CNBC. There's was a huge turf battle within the FDA that let to just the approvable letter. It really could be the basis for a good book on the 'politics' involved in getting these drugs to market. One of these days I will elaborate.
No comments:
Post a Comment